TY -的T1 - < em > < / em >作者从摩根富林明——欧元pean Respiratory Journal JO - Eur Respir J SP - 1072 LP - 1073 DO - 10.1183/09031936.06.00023406 VL - 27 IS - 5 AU - Raghu, G. AU - Johnson, W. C. Y1 - 2006/05/01 UR - //www.qdcxjkg.com/content/27/5/1072.2.abstract N2 - We appreciate the important concern raised by M. Thomeer and agree that following a standardised diagnostic criteria is important for both the investigator as well as the clinician taking care of the patients in the community. While the general pulmonologist may not be as “accurate” in diagnosing idiopathic pulmonary fibrosis (IPF) as expert clinicians involved in the diagnosis and management of IPF and other subgroups of idiopathic interstitial pneumonias (IIP) in tertiary centres enrolling patients in clinical trials, the clinical knowledge of IPF has evolved significantly with new data and clarifications during the last few years. Recent international consensus statements by the American Thoracic Society (ATS) and the European Respiratory Society (ERS) have increased the awareness of the different entities of IIP and IPF 1, 2. Thus, the current generation of general pulmonologists, as well as experienced pulmonologists, involved in active care of patients with pulmonary diseases are becoming quite familiar with the diagnostic criteria for these entities. In fact, all of the recent and ongoing clinical trials have utilised well-defined criteria based on set guidelines to enrol the most appropriate patients. The striking similarity of the baseline demographics in the patient populations enrolled in two recent separate multicentre clinical trials in … ER -